Ashok Vinayak Purandare,David B. Frennesson,Muthoni G. Kamau,Lalgudi S. Harikrishnan,Mark G. Saulnier
申请号：
US13123305
公开号：
US08445676B2
申请日:
2009.10.08
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof.The formula I compounds inhibit tyrosine kinase activity of such as Jak2 and CK2, thereby making them useful as antiproliferative agents for the treatment of cancer and other diseases.
